Coronavirus models are seen with a colorized image of a scanning electron micrograph of a cell (red) infected with the Omicron strain of the virus (blue). (NIAID) The coronavirus has been a shifty foe ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.
The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...
Drug startup LambdaVision is shooting for the stars with an ambitious plan to develop the world’s first cure for genetic blindness — from space. LambdaVision was founded in 2009 with a mission to ...
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
WASHINGTON — The Biden administration on Tuesday announced three new drug pricing policy experiments that would standardize how much Medicare patients pay for certain generic drugs, pilot new ways for ...
WXYZ Detroit, an ABC affiliate, reports that Vertex Pharmaceuticals said Tuesday the drug’s use in late-stage clinical trials resulted in “clinically meaningful ...
Hosted on MSN
NIH won’t renew ‘cruel’ drug experiments on beagle puppies — some as young as 8 months old
WASHINGTON — China-led drug tests on hundreds of beagle puppies won’t be conducted anymore on the US taxpayers’ dime, the National Institutes of Health (NIH) confirmed to The Post on Thursday — but ...
The coronavirus has been a shifty foe, with new variants and subvariants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback